STAT

Opinion: Medicare’s ‘catastrophic insurance’ can be a catastrophe for middle-income seniors

If you think Medicare will cover your drug costs, think again.

Pam Holt, a teacher and school administrator in Granger, Indiana, was looking forward to her retirement. After her husband died when she was 40, she raised three children alone. She paid into a pension, made Medicare and Social Security contributions, accumulated some savings, and was only three years away from paying off her mortgage when, at age 66, she was diagnosed with multiple myeloma, a cancer that originates in bone marrow. Fortunately for her, taking a pill called Revlimid, made by Celgene, can hold the disease at bay. But its cost began eating her up.

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Gene Therapies For Deafness Dredge Up An Old Question: Do Deaf People Want A ‘Cure’?
As scientists celebrate gene therapy's ability to enable hearing, deaf people are feeling a familiar dread: Are we endangered?
STAT1 min read
Opinion: STAT+: Unmasking The ‘Centricity’ Illusion In Clinical Trials
The glacial pace of change in mechanistic but essential areas of clinical trials undermines the biopharma industry's claims of progress and compassion.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Deal For A Moderna Bird Flu Shot, NIH Trial Shortcomings, And More
The U.S. government is nearing an agreement to bankroll a late-stage trial of Moderna’s mRNA pandemic bird flu vaccine, hoping to bolster its pandemic stockpile.

Related Books & Audiobooks